2025 Expert Speaker Faculty

Alice Fitzpatrick

Associate Director, Gene Therapy

Fractyl Laboratories Inc.

Amanda Placone

Senior Director, External Innovation & Early Commercial Strategy

Eli Lilly & Co.

amy raymond headshot

Amy Raymond

Rare Diseases and Gene Therapy, Therapeutic Strategy

Worldwide Clinical Trials

Andrew Knudten

Chief Executive Officer

Advanced Medicine Partners

Andy Kinley

Vice President - Innovation & Clinical Science

Precision for Medicine

Anjulika Chawla

Senior Director - Clinical Research Medical

bluebird bio

Annahita Keravala

Co-Founder & CSO

Genascence Corporation

Aron Stein

Senior Vice President - Global Regulatory Affairs

Intellia Therapeutics

Brian Baker

Senior Director, Companion Diagnostics Regulatory Affairs

Regeneron Pharmaceuticals Inc

Brian Furmanski

Chief Regulatory Officer

Kriya Therapeutics

Carrie Edwards Wolkoff

National Account Director

Spark Therapeutics

Chris Williams

Principal Engineer

Roche

Daniel Chung

Chief Medical Officer

SparingVision

Darshna Patel

Vice President - Regulatory Affairs

Neurocrine Biosciences

Deborah Phippard

Chief Scientific Officer

Precision for Medicine

Denise Gavin - FDA HEADSHOT

Denise Gavin

Director - Office of Gene Therapy

FDA

Doreen Morgan

Vice President, Head of Global Regulatory Strategy

Formerly of PTC Therapeutics

Faraz Ali

Chief Executive Officer

Tenaya Therapeutics

Frank Bugg

Global Head, BaseCamp Operations

Elevate Bio

Frederic Chereau

Senior Vice President - Strategy & Business Development

Alexion Pharmaceuticals

Gail Ryan

Director of Pharmaceutical Transformation

Point32Health

Heather Lau

Executive Director

Ultragenyx Pharmaceutical Inc

Howard Wu

Co-founder and CSO

Full Circles Therapeutics

Jacob Greenwood

VP, Strategy

Project Farma (PF)

Jacose Bell

Director, Patient Advocacy

Spark Therapeutics

Jim Wang

Vice President - Regulatory Affairs & Genetic Medicines

Regeneron

John Bishai

Managing Director, Healthcare Investment Banking

Bank of America Corp.

Jorge Marques Signes

Vice President - Advance Therapeutics Services

Azzur Group

Julia Taravella

Executive Director

Rare Trait Hope Fund

Julie Hakim

Chief Financial Officer

Capsida Biotherapeutics

Kali Stasi

Senior Vice President - Clinical Development

Adverum

Kathleen Kirby

COO

Merlin Therapeutics

Keith Wonnacott

Vice President - Regulatory Affairs

Lexeo Therapeutics

Khandan Baradaran

VP Regulatory CMC

Ultragenyx Pharmaceutical Inc

Kip Bitok

Director, Healthcare Investment Banking

Chardan Capital Markets

Kumar Dhanasekharan

SVP Technical Operations

Voyager Therapeutics

Lawrence Kau

Commercial Development

Spark Therapeutics

Liz Fowler

Director, CMS Innovation Center

Centers for Medicare & Medicaid Services

Lucia Fernandez

Director - Process Development & Manufacturing

Vinta Bio

Mantej (Nimi) Chhina

Executive Director

BioMarin Pharmaceutical

Maria Lalioti

Former Vice President - New Opportunities

Beam Therapeutics

Mark Trusheim

Strategic Director

Tufts Medical Center

Mayo Pujols

Executive Vice President And Chief Technical Officer

Rocket Pharmaceuticals Ltd.

Meisam Kararoudi

Principal Investigator, Center for Childhood Cancer

Nationwide Children's Hospital

Mi Jin

Senior Director, Head of Downstream & Drug Product Development

Spark Therapeutics

Michael Lehmicke

Senior Vice President - Science & Industry Affairs

Alliance for Regenerative Medicine

Michael Ruggiero

Senior Vice President, Global Policy, Advocacy And Government Affairs

CSL Behring

Michael Sherman

Venture Partner

RA Capital Management

Mitra Tavakkoli

Vice President, Clinical Development

Formerly of 4D Molecular Therapeutics

Monica Hayhurst Bennett

Head of Gene Therapy Unit, Neuroscience

Novartis

Monika Pema - AGC Biologics headshot

Monika Pema

Snr Manager Process Validation

AGC Biologics

Pat Furlong

Founding President & Chief Executive Officer

Parent Project Muscular Dystrophy

Peter Marks

Director

FDA

Philip John (P.J.) Brooks

Deputy Director - Office of Rare & Diseases Research

National Institutes of Health

Ravi Iyer

Chief Scientific Officer

Script Biosciences

Richard Colvin

Chief Medical Officer

bluebird bio

Robert Lu

Vice President - Technical Operations

Frontera Therapeutics

Sarah Wassmer

Quality Evaluator, Cells, Gene Therapies and Radiopharmaceuticals Division

Health Canada

Sebastian Aguirre

Co-Founder & Head of Platform Development

Carbon Biosciences

Sheila Mikhail

Co-Founder & Former Chief Executive Officer

AskBio

Sherif Gabriel

Senior Vice President, Head of Research and Development

AskBio

Shinichi NODA

Deputy Reviewer Director

PMDA

Soumi Gupta

Executive Director, Head of Clinical Immunology

BioMarin Pharmaceutical

SOURAV CHOUDHURY

Lab Head

Sanofi

Stacey Borenstein

Biologist

US Food & Drug Administration (FDA)

Sue Marrichi

Vice President & Site Head, Gene Therapy Manufacturing Facility

Ultragenyx Pharmaceutical Inc

Suzanne Plezier – Jonkheer

Senior Director - Clinical Operations

bluebird bio

Tayler shebly

senior director cmc regulatory affairs

Akouos Inc.

Terry Pirovolakis

Founder & Chief Executive Officer

Elpida Therapeutics

Tessa Field

Director, Patient Advocacy

Spark Therapeutics

Tim Hunt

Chief Executive Officer

Alliance for Regenerative Medicine

TJ Cradick

Chief Scientific Officer

Excision BioTherapeutics Inc.

Trent Lyman

Director Process Development

Matica Biotechnology

Wendy Larson

Director - Regulatory Affairs Chemistry, Manufacturing, & Controls

Astellas Innovation Management LLC

Wenning Qin

SVP Research

eGenesis Inc.

Xingmei Zhang

Franchise Program Lead

Hansa Biopharma

many more to be confirmed soon!

CHECK OUT THE 2024 FULL EVENT GUIDE